Lecap Asset Management Ltd. Buys Shares of 8,981 The Cooper Companies, Inc. (NASDAQ:COO)

Lecap Asset Management Ltd. acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 8,981 shares of the medical device company's stock, valued at approximately $991,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Benjamin F. Edwards & Company Inc. increased its stake in Cooper Companies by 248.6% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company's stock valued at $25,000 after purchasing an additional 174 shares in the last quarter. Innealta Capital LLC bought a new stake in Cooper Companies in the 2nd quarter valued at about $25,000. Covestor Ltd raised its stake in Cooper Companies by 305.9% during the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company's stock worth $28,000 after buying an additional 208 shares during the period. Crewe Advisors LLC boosted its holdings in Cooper Companies by 286.4% in the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company's stock worth $30,000 after acquiring an additional 252 shares in the last quarter. Finally, Tortoise Investment Management LLC boosted its holdings in Cooper Companies by 75.4% in the second quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company's stock worth $34,000 after acquiring an additional 169 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

Analyst Ratings Changes

A number of research analysts have weighed in on COO shares. Morgan Stanley raised their price objective on shares of Cooper Companies from $95.00 to $104.00 and gave the company an "equal weight" rating in a research note on Tuesday, September 10th. Jefferies Financial Group raised shares of Cooper Companies from a "hold" rating to a "buy" rating and raised their price target for the company from $107.00 to $115.00 in a research report on Tuesday, July 16th. Robert W. Baird boosted their price objective on Cooper Companies from $118.00 to $125.00 and gave the stock an "outperform" rating in a report on Thursday, August 29th. Stifel Nicolaus restated a "buy" rating and issued a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Finally, Piper Sandler lifted their target price on Cooper Companies from $115.00 to $120.00 and gave the company an "overweight" rating in a research report on Thursday, August 29th. Three research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $115.00.

Cooper Companies Stock Performance

Shares of Cooper Companies stock traded up $1.98 during trading hours on Thursday, hitting $107.30. 3,239,608 shares of the company's stock traded hands, compared to its average volume of 1,117,830. The stock has a market capitalization of $21.37 billion, a price-to-earnings ratio of 61.95, a PEG ratio of 2.56 and a beta of 0.98. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $112.38. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The company has a fifty day simple moving average of $105.15 and a 200-day simple moving average of $96.58.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The firm's quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter last year, the company posted $0.84 earnings per share. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.65 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the sale, the chief executive officer now owns 165,273 shares of the company's stock, valued at approximately $18,267,624.69. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares of the company's stock, valued at approximately $520,488.54. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Albert G. White III sold 114,992 shares of the business's stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the transaction, the chief executive officer now directly owns 165,273 shares of the company's stock, valued at approximately $18,267,624.69. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 256,373 shares of company stock valued at $27,637,427 over the last ninety days. 2.00% of the stock is currently owned by insiders.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.